Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic.
Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic.
复制标题
DOI：
10.1016/j.drugpo.2020.103053
复制
发表时间：
2021-06
期刊：
影响因子：
--
通讯作者：
Kruger DJ
中科院分区：
文献类型：
--
作者：
Boehnke KF;McAfee J;Ackerman JM;Kruger DJ
持续的COVID-19大流行使医疗系统紧张，限制了获得医疗服务的机会。许多人在医学上使用大麻治疗慢性健康状况，并作为其他药物的替代品。因此，与COVID-19相关的大麻获取变化可能导致非大麻药物使用增加。我们通过Amazon Mechanical Turk招募了N = 353人，他们在2020年4月和5月报告了当前的医用大麻使用情况。我们评估了COVID-19大流行对药物和物质使用模式以及大麻使用模式的影响。由于COVID-19大流行，超过一半的参与者开始使用或增加使用药物或物质，最常见的是酒精和睡眠辅助剂。超过三分之一的参与者增加了大麻的使用，而25%的人减少了大麻的使用。大约40%的增加或开始使用药物/物质（大麻除外）的参与者报告说，这样做是因为改变了获得医用大麻的途径。据报告，医用大麻使用者中的吸毒人数增加令人关切。由于大流行可能会持续数月（甚至数年），因此更好地了解为什么会发生这种情况对于在这一人群中制定有效的减少危害策略至关重要。
The ongoing COVID-19 pandemic strains the medical system, limiting access to healthcare services. Many people use cannabis medically for chronic health conditions and as a substitute for other medications. As such, changes in cannabis access associated with COVID-19 may result in increased non-cannabis drug use. We recruited N = 353 individuals through Amazon Mechanical Turk who reported current medical cannabis use in April and May of 2020. We assessed the effects of the COVID-19 pandemic on patterns of medication and substance use, as well as on cannabis use patterns. Over half of participants either started using or increased use of medications or substances because of the COVID-19 pandemic, most commonly alcohol and sleep aids. Over a third of participants increased cannabis use while 25% decreased cannabis use. Approximately 40% of participants who increased or started use of medications/substances (other than cannabis) reported doing so because of changed access to medical cannabis. The reported increase in drug use among people using medical cannabis is concerning. Because the pandemic will likely continue for months (or even years), having a better understanding of why this is occurring is critical for developing effective harm-reduction strategies in this population.
登录
查看更多内容
影响因子：
4
作者：
Boehnke, Kevin F.;Scott, J. Ryan;Clauw, Daniel J.
通讯作者：
Clauw, Daniel J.
影响因子：
4.2
作者：
Wall, Melanie M.;Liu, Jun;Olfson, Mark
通讯作者：
Olfson, Mark
影响因子：
4.2
作者：
Han, Beth;Compton, Wilson M.;Jones, Christopher M.
通讯作者：
Jones, Christopher M.
影响因子：
4.4
作者：
Lucas, Philippe;Baron, Eric P.;Jikomes, Nick
通讯作者：
Jikomes, Nick
影响因子：
4.4
作者：
Lin, Lewei A.;Ilgen, Mark A.;Bohnert, Kipling M.
通讯作者：
Bohnert, Kipling M.